JavaScript NENÍ povolen !

* Zobrazit nápovědu

Pracoviště: Dpt of Hemato oncology University Hospital Pils...

1 záznamů v Medvik Filtry

Článek

De novo accelerated phase of chronic myeloid leukemia should be recognized even in the era of tyrosine kinase inhibitors

Hornak, Tomas
Autor Hornak, Tomas ORCID Dpt. of Internal Medicine Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic
Mayer, Jiri
Autor Mayer, Jiri Dpt. of Internal Medicine Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic
Cicatkova, Petra
Autor Cicatkova, Petra Dpt. of Internal Medicine Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic
Semerad, Lukas
Autor Semerad, Lukas Dpt. of Internal Medicine Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic
Kvetkova, Anezka
Autor Kvetkova, Anezka Dpt. of Internal Medicine Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic
Klamova, Hana
Autor Klamova, Hana Institute of Hematology and Blood Transfusion, Prague, Czech Republic
Faber, Edgar
Autor Faber, Edgar Dpt. of Hemato-oncology, University Hospital Olomouc and Palacky University, Olomouc, Czech Republic
Belohlavkova, Petra
Autor Belohlavkova, Petra ORCID 4th Dpt. of Internal Medicine and Hematology, University Hospital Hradec Kralove and Charles University, Hradec Kralove, Czech Republic
Karas, Michal
Autor Karas, Michal Dpt. of Hemato-oncology, University Hospital Pilsen and Charles University, Pilsen, Czech Republic
Stejskal, Lukas
Autor Stejskal, Lukas Dpt. of Hematooncology, University Hospital Ostrava, Ostrava, Czech Republic Dpt. of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic

American journal of hematology. 2024 ; 99 (4) : 763-766. [pub] 20240205

Am J Hematol
ISSN 1096-8652
Medvik
Zdroj

Overall survival of patients classified according to the European LeukemiaNet 2020 classification. Chronic phase (CP), accelerated phase (AP), blast crisis (BC), low risk (LR), intermediate risk (IR), high risk (HR).

MeSH
blastická krize farmakoterapie MeSH
chronická myeloidní leukemie * farmakoterapie MeSH
inhibitory proteinkinas terapeutické užití MeSH
inhibitory tyrosinkinasy * MeSH
lidé MeSH
Check Tag
lidé MeSH
Publikační typ
dopisy MeSH

Kolekce

Publikováno

Filtry

* Zobrazit nápovědu

* Zobrazit nápovědu

Upřesnit dle MeSH